Thyroscope Inc.

400M patients suffer from thyroid dysfunction and thyroid eye disease, a complication of the dysfunction. With a vision of "innovating standard of care to create values for patients and doctors", THYROSCOPE developed the world's first digital monitoring solution for thyroid dysfunction and thyroid eye disease, and is currently working on CE marking and FDA approval focusing on Germany and US with a strong global clinical trial team in each region.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved